DOSSIER · 13F-HR · Q3 2026

EAGLE WEALTH STRATEGIES LLC

$263M in tracked AUM across 116 positions as of Q3 2026.

EW
CIK 0002009882 · last filed Sep 30, 2026
Total AUM
$263M
as of Q3 2026
Holdings
116
—
positions
Whale Score
63
63
tracked
Activity
—
no data
changes this Q
AI Analysis · Q3 2026

Eagle Wealth Strategies' $261.7 million book (Q2 2026, up 14.8% from $228.1 million) shows a distinct three-name pattern: Advanced Micro Devices (AMD), Micron (MU), and Marvell Technology (MRVL) each saw their position values surge — AMD up 152% to $3.0 million, Micron up 238% to $1.9 million, Marvell up 193%, nearly tripling, to $1.5 million — while the manager was trimming shares in all three (AMD -11.6%, Micron -0.9%, Marvell -2.7%). Rather than riding the rally passively, Eagle Wealth took profit into strength across its entire semiconductor sleeve. The rest of the book leans heavily on factor ETFs: Vanguard S&P 500 (VOO, 22.9%), Avantis U.S. Small Cap Value (AVUV, 12.4%), Franklin FTSE Multifactor (FLQM, 10.4%), Dimensional Emerging Markets Value (DFEV, 7.9%), and WisdomTree Quality Dividend Growth (DGRW, 7.3%) together make up 60.8% of assets — a deliberate factor-tilt structure, not a diversified index hug. The sole sector-specific bet is Health Care Select Sector SPDR (XLV) at 4.6%, grown 5.5% in shares this quarter with no offsetting sector position elsewhere in the book — a real, standalone conviction call. New stakes appeared in SPDR Gold Trust (GLD) and a position tied to Space Exploration Technologies (SPCX), while Northrop Grumman (NOC), Verizon (VZ), and Johnson & Johnson (JNJ) were exited outright.

The rest of the $261.7 million book is structured around explicit factor exposure rather than broad diversification. Five funds — Vanguard S&P 500 (VOO, 22.9%), Avantis U.S. Small Cap Value (AVUV, 12.4%), Franklin FTSE Multifactor (FLQM, 10.4%), Dimensional Emerging Markets Value (DFEV, 7.9%), and WisdomTree U.S. Quality Dividend Growth (DGRW, 7.3%) — together account for 60.8% of assets. That's core beta (VOO) layered with small-value, international multifactor, emerging-market value, and quality-dividend tilts: a factor-investing playbook, not an index-tracking one.

Outside that factor core, Eagle Wealth carries exactly one sector-specific bet: Health Care Select Sector SPDR (XLV), at 4.6% of assets and grown another 5.5% in shares this quarter. No other GICS sector fund appears anywhere in the book, which makes XLV read as a genuine standalone call on health care rather than one piece of a balanced sector rotation.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q3 2026. Methodology

Quarter at a glance — Q3 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q3 2026.

#HoldingValueSharesWeight
01
VOO
VANGUARD INDEX FDS
$62M88K23.4%
02
AVUV
AMERICAN CENTY ETF TR
$30M253K11.3%
03
FLQM
FRANKLIN TEMPLETON ETF TR
$27M473K10.3%
04
DFEV
DIMENSIONAL ETF TRUST
$20M464K7.5%
05
DGRW
WISDOMTREE TR
$19M197K7.3%
06
XLV
SELECT SECTOR SPDR TR
$13M75K4.8%
07
XOM
EXXONMOBIL HOLDINGS CORP
$5M30K1.8%
08
LLY
ELI LILLY & CO
$5M4K1.8%
09
AMZN
AMAZON COM INC
$5M19K1.8%
10
MSFT
MICROSOFT CORP
$4M8K1.5%

Filing history

2026Q3Sep 30
$263M▲ 0.5%
116 positionsView →
2026Q2Jun 30
$262M▲ 14.8%
118 positionsView →
2026Q1Mar 31
$228M▲ 6.2%
114 positionsView →
2025Q4Dec 31
$215M▲ 127.2%
114 positionsView →
2025Q3Sep 30
$94M▼ 47.1%
51 positionsLocked
2025Q2Jun 30
$179M▲ 9.7%
105 positionsLocked
2025Q1Mar 31
$163M▲ 18.0%
97 positionsLocked
2024Q4Dec 31
$138M▲ 0.7%
105 positionsLocked
2024Q3Sep 30
$137M▲ 10.8%
110 positionsLocked
2024Q2Jun 30
$124M▲ 0.5%
89 positionsLocked
2024Q1Mar 31
$123M▼ 25.8%
94 positionsLocked
2023Q4Dec 31
$166M—
98 positionsLocked